Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.14 -0.02  (-0.93%)
TradingVolume：4271.3
08-26
2014
TRADING HALT
Publisher：
08-22
2014
Announcement - Partnership with HANMI to Develop Oncology Drug in China
Publisher：
08-22
2014
Interim Results Announcement for the six months ended 30 June 2014
Publisher：
08-11
2014
Notice of Board Meeting
Publisher：
08-06
2014
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2014
Publisher：
08-01
2014
Stabilizing Actions and End of Stabilization Period
Publisher：
07-21
2014
Approval for Clinical Trial for New Chemical Drug Evogliptin Tartrate Tablets
Publisher：
07-16
2014
Full Exercise Of Over-Allotment Option
Publisher：
07-09
2014
Terms of Reference for Nomination Committee
Publisher：
07-09
2014
Altered Memorandum of Association and Bye-laws
Publisher：
First
48
49
50
51
52
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：4271.3
2.14
-0.02  (-0.93%)
Announcement & Circular
08-26
2014
TRADING HALT
08-22
2014
Announcement - Partnership with HANMI to Develop Oncology Drug in China
08-22
2014
Interim Results Announcement for the six months ended 30 June 2014
08-11
2014
Notice of Board Meeting
08-06
2014
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 July 2014
08-01
2014
Stabilizing Actions and End of Stabilization Period
07-21
2014
Approval for Clinical Trial for New Chemical Drug Evogliptin Tartrate Tablets
07-16
2014
Full Exercise Of Over-Allotment Option
07-09
2014
Terms of Reference for Nomination Committee
07-09
2014
Altered Memorandum of Association and Bye-laws
First
48
49
50
51
52
Last